CN101966263A - SOD (Super Oxide Dlsmutase) oxidation-resistant health product - Google Patents
SOD (Super Oxide Dlsmutase) oxidation-resistant health product Download PDFInfo
- Publication number
- CN101966263A CN101966263A CN 201010509969 CN201010509969A CN101966263A CN 101966263 A CN101966263 A CN 101966263A CN 201010509969 CN201010509969 CN 201010509969 CN 201010509969 A CN201010509969 A CN 201010509969A CN 101966263 A CN101966263 A CN 101966263A
- Authority
- CN
- China
- Prior art keywords
- sod
- oxidation
- health product
- extract
- extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 21
- 230000003647 oxidation Effects 0.000 title abstract description 5
- 238000007254 oxidation reaction Methods 0.000 title abstract description 5
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 title abstract description 3
- 239000000284 extract Substances 0.000 claims abstract description 24
- 230000003064 anti-oxidating effect Effects 0.000 claims abstract description 19
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 15
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 15
- 229940082787 spirulina Drugs 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 9
- 235000009392 Vitis Nutrition 0.000 claims description 8
- 241000219095 Vitis Species 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 150000003254 radicals Chemical class 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 6
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 230000037356 lipid metabolism Effects 0.000 abstract description 2
- 229910052760 oxygen Inorganic materials 0.000 abstract description 2
- 239000001301 oxygen Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 210000002966 serum Anatomy 0.000 abstract description 2
- 241000414067 Inonotus obliquus Species 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 235000002532 grape seed extract Nutrition 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 235000003969 glutathione Nutrition 0.000 description 5
- 229960003180 glutathione Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010018275 Gingival atrophy Diseases 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- -1 Hetero polysaccharide Chemical class 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000001943 adrenal medulla Anatomy 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 201000005562 gingival recession Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010044278 Trace element deficiency Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000003161 proteinsynthetic effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000008700 sympathetic activation Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an SOD (Super Oxide Dlsmutase) oxidation-resistant health product which is prepared from the following components in parts by weight: 50 to 90 of grape seed extracts, 30 to 60 of natural VC, 45 to 60 of spirulina platensis extracts and 45 to 60 of inonotus obliquus extracts. The SOD oxidation-resistant health product has the synergistic effect of all the components, is rich in the antioxidation of SOD and has free radical balancing and anti-aging function. The SOD contained in the preparation has the advantages of maintaining longer survivability, enhancing antioxidation capacity, eliminating excess oxygen free radicals, regulating lipid metabolism in the human body, preventing the increase of serum total cholesterol and triglycerides, protecting cardiac and cerebral blood vessels, enhancing and improving human body immunity capacity and having more SOD activity units in finished products.
Description
Technical field
The invention belongs to a kind of Medicines and Health Product technical field, the capsule that particularly has antioxidation.Can be made into powder, tablet, capsule etc.The present invention does not contain any chemical reagent, is the anti-oxidation health product of pure natural.
Background technology
Aging is the human irresistible natural law, mainly is by smearing skin, can only playing whitening or the delaying decrepitude of skin effect to skin to the skin anti-aging product much at present.By oral SOD anti-oxidation health product of the present invention, can reach efficient removing free radical antioxidation, skin and play and whiten and the effect of slow down aging, cosmetology and health.The effect that also has cardiovascular diseases, cerebrovascular, malignant tumor, senile dementia and other senile disease such as prophylaxis of hypertension, diabetes.The present invention does not contain any chemical reagent, is the SOD anti-oxidation health product of pure natural.
Summary of the invention
The object of the invention provides a kind of SOD anti-oxidation health product, to satisfy people's health care needs.
Scientific research proves: old and feeble arch-criminal---free radical.The free radical that oxidisability is extremely strong can cause very big injury to organism.So the effect of free radical is to cause the most essential old and feeble reason.Therefore the method for slow down aging is an inhibited oxidation.The present invention is according to this theory, the SOD anti-oxidation health product of proposition, and it is formulated with the following weight parts component: Semen Vitis viniferae extract 50-90, natural VC 30-60, spirulina plalensis extract 45-60, Phaeoporus obliquus extract 45-60.
Preferential the consisting of of recommending of the present invention: Semen Vitis viniferae extract 70, natural VC 50, spirulina plalensis extract 55, Phaeoporus obliquus extract 55.
Semen Vitis viniferae extract (the OPC that the present invention adopts, procyanidin) is natural powerful antioxidant, it is one of efficient antioxidants of the plant origin found so far, its antioxidant effect, stronger 50 times than vitamin E, stronger 20 times than vitamin C, superpower antioxidant effect has the powerful effect of removing free radical, improving body immunity.
And spirulina plalensis wherein is the human classic pure natural protein food source of being found up to now, and be that protein content is up to 60～70%, be equivalent to 6 times of Semen Tritici aestivi, 4 times of Carnis Sus domestica, the flesh of fish 3 times, 5 times of egg, 2.7 times of cheese, and digestibility is up to more than 95%.It is distinctive
Phycocyanin, can improve lymphocyte activity, strengthen body immunity, therefore gastrointestinal disease and hepatopath's rehabilitation are acquired a special sense.Wherein vitamin and content of mineral substances are very abundant, comprise vitamin B1, vitamin B2, vitamin B6, vitamin B 12,
Vitamin E,
Vitamin KDeng, and containing trace element such as zinc, ferrum, potassium, calcium, magnesium, phosphorus, selenium, iodine, its biological zinc, ferrum ratio need consistently with Human Physiology substantially, and the easiest being absorbed by the body can be improved child's apositia fast, appetite stimulator.Its carotenoid content is 15 times of Radix Dauci Sativae, and vitamin B12 content is 4 times of Hepar Sus domestica, and iron content is 23 times of Herba Spinaciae, is the abundantest food of iron content, and therefore, spirulina is to control
AnemiaPositive effect is arranged.Contain a large amount of gamma-Linolenic acids, this is a kind of unsaturated fatty acid of needed by human, is nourishing the brain and improving intelligence, the desirable material of removing blood fat, blood pressure regulation, cholesterol reducing.Spirulina polysaccharide in the spirulina has
RadioprotectiveTherefore damage and the side reaction effect that improvement is put, chemotherapy causes are the dietetic therapy good merchantable brands to tumor patient.Chlorophyll content is very abundant in the spirulina, is more than 10 times of common vegetable content, to promoting human consumption, in and septicemia plain and improve allergic constitution, eliminating internal organs inflammation etc. all has positive role.Fat content has only 5% in the spirulina, and does not contain cholesterol, can make human body avoid the Excessive Intake heat when replenishing necessary albumen.Prove through a large amount of scientific research and testing both at home and abroad, spirulina is at cholesterol reducing and blood fat, anticancer, fat-reducing, stomach is protected in nourishing the stomach, treatment anemia and trace element deficiency, hepatoprotective, promote immunity, all there is positive role aspects such as adjustment metabolism, are recommended as " optimal food of 21st century " by FAO (Food and Agriculture Organization of the United Nation) and world's food association of the United Nations.
The contained SOD. of raw material Phaeoporus obliquus (superoxides disproportionation ferment) is up to 50000U/g.And contain Plant fiber's class polysaccharide body of a large amount of anticancer, blood sugar lowering, resurrection immunization.As materials such as the 2-Glucan of cell membrane component, Kitchea matter, Hetero polysaccharide, Pectinquality.Particularly the 2-Glucan content in the BRM material of polysaccharide is higher.It is the vigor that improves immunocyte, and anticancer diffusion and recurrence prevent the absorption of harmful substances such as carcinogen in gastrointestinal, and promotes to drain.
And natural complex c wherein, recent studies shows that VC is most important to health:
1. collagen protein synthetic needs vitamin C to participate in, thus VC lack edible be rich in ascorbic food can be sun-proof, collagen protein can not normally synthesize, and causes the cell asynthesis.Human body is made up of cell, and cell connects them by intercellular substance, and the key component of intercellular substance is a collagen protein.It is proteinic 1/3 that collagen protein accounts for health, generates connective tissue, constitutes the health skeleton.As skeleton, blood vessel, ligament etc., determined the elasticity of skin, protect brain, and help the healing of human body wound.
2. vitamin C deficiency.The intensity and the VC of blood vessel wall have much relations.Blood capillary is the most tiny in all blood vessels, and tube wall may have only the thickness of a cell, and its intensity, elasticity are determined by the collagen protein that responsible connection cell has the clay effect.VC deficiency in body, blood capillary is broken easily, and blood flows to adjacent tissue.This situation takes place at skin surface, then produces congestion, purple abnormal pigmentary deposit on the skin; Take place in vivo to cause that then pain and joint go up painful.Serious situation all can have bleeding below stomach, intestinal, nose, kidney and periosteum, and even dead.
3. gingival atrophy, hemorrhage.Healthy dental bed tightly encases each tooth.Gingiva is a soft tissue, easily produces gingival atrophy, hemorrhage when lacking protein, calcium, VC.
4. prevention of arterial sclerosis.Can promote the drainage of cholesterol, prevent cholesterol, even can make sedimentary atheromatous plaque dissolving in tremulous pulse inwall deposition.
5. be a kind of water miscible strong antioxidant.Can protect other antioxidant, as vitamin A,
Vitamin E, unsaturated fatty acid, prevent the injury of radical pair human body.
6. treatment anemia.Make the ferric iron that is difficult to absorb be reduced into ferrous iron, promote the absorption of intestinal, improve the utilization rate of liver, help to treat iron deficiency anemia ferrum to ferrum.
7. give protection against cancer.Abundant collagen protein helps to prevent the diffusion of cancerous cell; The injury that the antioxidation of VC can be resisted the radical pair cell prevents the variation of cell; Blocking-up nitrite and secondary amine form strong carcinogen nitrosamine.The people was once arranged to finding that because of the cancer mortality patient anatomy the intravital VC content of patient is almost nil.
8. protection cell, detoxifcation, the liver protecting.In people's vital movement, guarantee cell integrity and metabolic normally carry out most important.For this reason, glutathion and enzyme play an important role.The small peptide that glutathion is made up of glutamic acid, cystine and glycine has redox in vivo.It has two kinds of existence forms, i.e. oxidized form and reduced form, and reduced form plays an important role to the integrity that guarantees cell membrane.
VC is a kind of powerful antioxidant, and itself is oxidized, and makes oxidized form of glutathione be reduced to reduced glutathion, thus the performance antioxidation.Enzyme is the catalyst of biochemical reaction, and some enzyme require has freely the coloured glaze base (SH) could keep active.VC can make cystine linkage (S-S) be reduced to-SH, thereby the activity of raising relevant enzyme be brought into play the antioxidative effect.
From as can be known above, as long as the VC abundance, then VC, glutathion ,-SH forms strong antioxidation set boxing, removes free radical, stops the toxic action of lipid peroxidation and some chemical substance, the homergy of liver-protective detoxification ability and cell.
9. improve the immunity of human body.
Leukocyte contains abundant VC, and intraleukocytic VC sharply reduces when organism infection.VC can strengthen the chemotaxis and the deformability of neutrophilic granulocyte, improves sterilizing ability.
Promote lymphoblastic generation, improve body to the identification of external and malignant cell with kill.Participate in the synthetic of immunoglobulin.Improve CI complement esterase active, increase the generation of complement CI.Promote the generation of interferon, viral interference mRNA transcribes, and suppresses the hypertrophy of virus.
10. improve the emergency capability of body.Human body is subjected to unusual stimulation, as severe pain, cold, anoxia, spiritual strong stimulation, can cause the tense situation of resisting abnormal stimulation.This state comprises sympathetic activation, adrenal medulla and 17-hydroxy-11-dehydrocorticosterone secretion increasing with a series of healths.Epinephrine that adrenal medulla is secreted and norepinephrine are to have tyrosine to be transformed, in the participation of inferior process need VC.
More than each component synergism; be rich in the antioxidation of SOD; have flat free radical and defying age, the contained SOD of this preparation can keep the viability of long period, has the enhancing oxidation resistance; eliminate the effect of excess of oxygen free radical; the intravital lipid metabolism of mediator prevents the rising of serum total cholesterol and triglyceride simultaneously, and cardiovascular and cerebrovascular vessel are had protective effect; strengthen and the raising human body immunity the many advantages of SOD active unit in the finished product.
The specific embodiment
Embodiment 1: SOD anti-oxidation health product of the present invention, it is formulated with the following weight parts component: Semen Vitis viniferae extract (0PC) 70mg, natural VC50mg, spirulina plalensis extract 55mg, Phaeoporus obliquus extract 55mg mix homogeneously can incapsulate.
Embodiment 2: SOD anti-oxidation health product of the present invention, it is formulated with the following weight parts component: Semen Vitis viniferae extract 50mg, natural VC60mg, spirulina plalensis extract 45mg, Phaeoporus obliquus extract 60mg.Each component mix homogeneously incapsulates and gets final product.
Embodiment 3: SOD anti-oxidation health product of the present invention, it is formulated with the following weight parts component: Semen Vitis viniferae extract 90mg, natural VC 30mg, spirulina plalensis extract 60mg, Phaeoporus obliquus extract 45mg.Each component mix homogeneously incapsulates and gets final product.
Claims (2)
1.SOD the anti-oxidation health product is characterized in that with the following weight parts component formulated: Semen Vitis viniferae extract 50-90, natural VC 30-60, spirulina plalensis extract 45-60, Phaeoporus obliquus extract 45-60.
2. SOD anti-oxidation health product according to claim 1 is characterized in that with the following weight parts component formulated: Semen Vitis viniferae extract 70, natural VC 50, spirulina plalensis extract 55, Phaeoporus obliquus extract 55.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010509969 CN101966263A (en) | 2010-10-18 | 2010-10-18 | SOD (Super Oxide Dlsmutase) oxidation-resistant health product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010509969 CN101966263A (en) | 2010-10-18 | 2010-10-18 | SOD (Super Oxide Dlsmutase) oxidation-resistant health product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101966263A true CN101966263A (en) | 2011-02-09 |
Family
ID=43545525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010509969 Pending CN101966263A (en) | 2010-10-18 | 2010-10-18 | SOD (Super Oxide Dlsmutase) oxidation-resistant health product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101966263A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103637192A (en) * | 2013-11-21 | 2014-03-19 | 威海五谷怡健食品有限公司 | Anti-aging health food and its preparation method |
| CN107890108A (en) * | 2017-11-10 | 2018-04-10 | 大连大学 | A kind of SOD health products of anti-skin oxidative |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101342366A (en) * | 2007-07-13 | 2009-01-14 | 刘安荣 | SOD oxidation resistant composition and preparation thereof |
-
2010
- 2010-10-18 CN CN 201010509969 patent/CN101966263A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101342366A (en) * | 2007-07-13 | 2009-01-14 | 刘安荣 | SOD oxidation resistant composition and preparation thereof |
Non-Patent Citations (2)
| Title |
|---|
| 《中老年保健》 20061130 魏文青 抗氧化剂--抗击自由基的卫士3 27 1-2 , 第11期 2 * |
| 《食用菌学报》 20060630 回晶等 桦褐孔菌多糖的体外抗氧化作用研究 29-31 1-2 第13卷, 第2期 2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103637192A (en) * | 2013-11-21 | 2014-03-19 | 威海五谷怡健食品有限公司 | Anti-aging health food and its preparation method |
| CN107890108A (en) * | 2017-11-10 | 2018-04-10 | 大连大学 | A kind of SOD health products of anti-skin oxidative |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106266700A (en) | A kind of Fructus Hippophae prescription bag alveolitoid medicinal tea allotment and manufacture method | |
| CN108835262A (en) | A kind of modulation milk powder and preparation method thereof improving memory | |
| CN104171025A (en) | Selenium-rich edible oil suitable for women and children | |
| US20090004168A1 (en) | Health Enhancement System | |
| CN1947600A (en) | Sun-rays proof beauty-care beverage | |
| CN113632851A (en) | Multifunctional children growth milk powder and preparation method thereof | |
| JP2008120761A (en) | Beauty and health food composed of shark fin extract, yolk lecithin and fermentation aged collagen (lcp) and its manufacturing method | |
| CN109527290A (en) | A kind of preparation method of beauty collagen peptide fruity beverage | |
| CN102018158A (en) | Aloe jam | |
| CN101147527A (en) | Feed capable of leading duck egg to have softening blood vessel and reducing blood pressure function and preparation method | |
| CN101966263A (en) | SOD (Super Oxide Dlsmutase) oxidation-resistant health product | |
| CN107028169A (en) | A kind of composition for improving memory and preparation method thereof | |
| CN101007055B (en) | Preparation method of eucommia pollen soft capsule rich in α-linolenic acid | |
| CN103933146A (en) | Pollen product capable of adjusting human body immunity | |
| KR20010079227A (en) | manufacturing method of a health supplement food for a chitosan and vitamin | |
| CN106509761A (en) | Health-care product having cell repair factors and effects of building body, beautifying features and prolonging life | |
| CN107411078A (en) | A kind of plant donkey-hide gelatin for blood-supplementing blood-nourishing | |
| CN1089215C (en) | Health milk powder with ginkgo leaf component | |
| CN116035213A (en) | An optimized dietary prescription of plant organic nano-selenium for activating the immune system, preventing cancer and tumors, anti-oxidation and anti-aging | |
| CN107890108A (en) | A kind of SOD health products of anti-skin oxidative | |
| CN1115977C (en) | Method for preparing compound combined meilatuoning health food series | |
| CN1350850A (en) | Soft capsule of superfine compound pearl powder and its preparing process | |
| CN104800826A (en) | Vitamin-microelement-peptide buccal tablet | |
| RU2351350C1 (en) | Set "predstar", its application and method of prevention of premature organism aging | |
| CN102919858A (en) | Soft capsule with aloe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20110209 |